Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
Unraveling the Mechanisms of Microbiome Modulation in Cancer Immunotherapy
EF 2023-24
Résumé
The human body is colonized by trillions of microbes on the skin, gut, and other locations, collectively known as the microbiome. While the microbiome consists of bacteria, viruses and fungi, host-bacteria interactions have been the best studied so far. In recent years, many studies have shown that the microbiome can be involved in cancer development, progression, and response to therapy. Studies have shown that patients who receive antibiotics, often killing large amounts of the beneficial microbes, prior to cancer immunotherapies experience worse outcomes. This highlights a tremendous potential to harness the microbiome for cancer therapy purposes. However, as this is a relatively new field of study, the underlying mechanisms by which bacteria influence the responses to cancer are still largely unknown. My project is focused on unraveling some of these mechanisms to better understand the ways in which the microbiome can influence cancer therapies, and how we can use this information to develop better cancer treatments. We are interested in looking at two different immunotherapies, immune checkpoint blockade therapy (ICBT) and CAR-T cell therapy, the first of which prevents our immune cells from getting tired promoting prolonged killing of cancerous cells and the second which are engineered immune cells that directly target cancer cells. We hypothesize that specific molecules produced by bacteria in the gut act together with these therapies to promote an overall stronger anti-cancer response than either of the therapies alone.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
506183
Name
Shupe Amy F
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Unraveling the Mechanisms of Microbiome Modulation in Cancer Immunotherapy
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Immunology; Immunotherapy; Metabolites; Microbiome
Abstract
The human body is colonized by trillions of microbes on the skin, gut, and other locations, collectively known as the microbiome. While the microbiome consists of bacteria, viruses and fungi, host-bacteria interactions have been the best studied so far. In recent years, many studies have shown that the microbiome can be involved in cancer development, progression, and response to therapy. Studies have shown that patients who receive antibiotics, often killing large amounts of the beneficial microbes, prior to cancer immunotherapies experience worse outcomes. This highlights a tremendous potential to harness the microbiome for cancer therapy purposes. However, as this is a relatively new field of study, the underlying mechanisms by which bacteria influence the responses to cancer are still largely unknown. My project is focused on unraveling some of these mechanisms to better understand the ways in which the microbiome can influence cancer therapies, and how we can use this information to develop better cancer treatments. We are interested in looking at two different immunotherapies, immune checkpoint blockade therapy (ICBT) and CAR-T cell therapy, the first of which prevents our immune cells from getting tired promoting prolonged killing of cancerous cells and the second which are engineered immune cells that directly target cancer cells. We hypothesize that specific molecules produced by bacteria in the gut act together with these therapies to promote an overall stronger anti-cancer response than either of the therapies alone.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shupe, Amy F
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~